Cargando…
Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
The role of the beta-adrenergic signaling pathway in heart failure (HF) is pivotal. Early blockade of this pathway with beta-blocker (BB) therapy is recommended as the first-line medication for patients with HF and reduced ejection fraction (HFrEF). Conversely, in patients with severe acute HF (AHF)...
Autores principales: | Schurtz, Guillaume, Mewton, Nathan, Lemesle, Gilles, Delmas, Clément, Levy, Bruno, Puymirat, Etienne, Aissaoui, Nadia, Bauer, Fabrice, Gerbaud, Edouard, Henry, Patrick, Bonello, Laurent, Bochaton, Thomas, Bonnefoy, Eric, Roubille, François, Lamblin, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693984/ https://www.ncbi.nlm.nih.gov/pubmed/38050613 http://dx.doi.org/10.3389/fcvm.2023.1263482 |
Ejemplares similares
-
Impact of Pre-Existing History of Heart Failure on Patient Profile, Therapeutic Management, and Prognosis in Cardiogenic Shock: Insights from the FRENSHOCK Registry
por: Schurtz, Guillaume, et al.
Publicado: (2022) -
Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry
por: Delmas, Clement, et al.
Publicado: (2021) -
One-year outcomes in cardiogenic shock triggered by ventricular arrhythmia: An analysis of the FRENSHOCK multicenter prospective registry
por: Cherbi, Miloud, et al.
Publicado: (2023) -
One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
por: Cherbi, Miloud, et al.
Publicado: (2023) -
IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)